Novo Nordisk just settled with Viatris, a company which was trying to have the Ozempic patent cancelled.[1] That would have killed their monopoly. "Terms of the

Novo Nordisk just settled with Viatris, a company which was trying to have the Ozempic patent cancelled.[1] That would have killed their monopoly. "Terms of the settlement are confidential". They just did the same thing with Mylan.[2] And may have done something similar with Rio Pharmaceuticals.[3] The Federal Trade Commission is also fighting that.[4] [1] https://www.reuters.com/legal/litigation/novo-nordisk-settles-us-patent-fight-with-viatris-over-ozempic-wegovy-2024-10-07/ https://www.reuters.com/legal/litigation/novo-nordisk-settle... [2] https://iplaw.allard.ubc.ca/2024/10/08/settlement-of-patent-case-with-potential-to-limit-reach-of-ozempic/ https://iplaw.allard.ubc.ca/2024/10/08/settlement-of-patent-... [3] https://www.pacermonitor.com/public/case/52064967/NOVO_NORDISK_INC_et_al_v_RIO_BIOPHARMACEUTICALS,_INC https://www.pacermonitor.com/public/case/52064967/NOVO_NORDI... [4] https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held-by-drugmakers-including-for-ozempic.html https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held-...